Stock Analysis on Net

KLA Corp. (NASDAQ:KLAC)

Income Statement 
Quarterly Data

KLA Corp., consolidated income statement (quarterly data)

US$ in thousands

Microsoft Excel
3 months ended: Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019
Product 2,472,182 2,393,821 2,409,462 2,197,389 1,954,837 1,769,369 1,921,809 1,836,664 1,816,524 1,903,484 2,463,408 2,195,609 1,975,112 1,800,659 1,895,769 1,629,888 1,481,478 1,375,320 1,238,023 1,145,495 1,075,104 1,051,096 1,144,550 1,057,975
Service 702,559 669,208 667,389 644,152 613,898 590,461 564,917 560,292 538,613 529,124 520,479 528,815 511,627 488,017 456,861 453,950 443,993 428,453 412,847 393,125 384,489 372,868 364,903 355,439
Revenues 3,174,741 3,063,029 3,076,851 2,841,541 2,568,735 2,359,830 2,486,726 2,396,956 2,355,137 2,432,608 2,983,887 2,724,424 2,486,739 2,288,676 2,352,630 2,083,838 1,925,471 1,803,773 1,650,870 1,538,620 1,459,593 1,423,964 1,509,453 1,413,414
Costs of revenues (1,207,286) (1,175,689) (1,221,461) (1,147,431) (1,010,551) (993,885) (976,746) (946,891) (962,949) (1,005,346) (1,208,786) (1,041,226) (978,564) (892,091) (908,162) (813,624) (772,241) (709,629) (669,733) (620,562) (621,544) (590,158) (633,618) (604,241)
Gross margin 1,967,455 1,887,340 1,855,390 1,694,110 1,558,184 1,365,945 1,509,980 1,450,065 1,392,188 1,427,262 1,775,101 1,683,198 1,508,175 1,396,585 1,444,468 1,270,214 1,153,230 1,094,144 981,137 918,058 838,049 833,806 875,835 809,173
Research and development (352,989) (338,043) (346,157) (323,145) (325,759) (321,590) (320,418) (311,214) (317,110) (328,276) (332,826) (318,515) (296,881) (285,189) (265,031) (258,153) (241,428) (238,957) (229,064) (219,038) (217,100) (215,433) (220,751) (210,580)
Selling, general and administrative (262,706) (248,905) (267,081) (251,042) (255,106) (237,514) (237,244) (239,645) (250,857) (238,393) (243,096) (253,980) (236,778) (216,489) (213,479) (193,261) (192,022) (183,040) (181,909) (172,631) (167,791) (185,760) (192,253) (188,345)
Impairment of goodwill and purchased intangible assets (239,100) (70,474) (219,000) (256,649)
Income from operations 1,351,760 1,300,392 1,003,052 1,119,923 977,319 736,367 733,318 899,206 824,221 860,593 1,199,179 1,110,703 974,516 894,907 965,958 818,800 719,780 672,147 570,164 526,389 453,158 175,964 462,831 410,248
Interest expense (73,125) (71,889) (74,981) (82,171) (82,836) (79,981) (74,202) (74,234) (73,491) (74,774) (74,280) (74,395) (44,197) (39,978) (37,852) (38,312) (39,970) (39,092) (38,880) (39,386) (40,221) (39,231) (40,472) (40,350)
Loss on extinguishment of debt (13,286) (22,538)
Other income (expense), net 50,164 35,930 44,458 40,935 50,560 45,622 32,154 26,739 24,776 14,864 18,074 47,006 19,380 (8,644) (1,201) (14,140) 29,033 7,348 (3,882) (3,197) (7,868) 1,004 2,568 1,618
Income before income taxes 1,328,799 1,264,433 972,529 1,078,687 945,043 702,008 691,270 851,711 775,506 800,683 1,142,973 1,070,028 949,699 846,285 926,905 766,348 708,843 640,403 527,402 483,806 405,069 115,199 424,927 371,516
(Provision) benefit for income taxes (125,950) (176,017) (148,002) (132,836) (108,597) (100,467) (108,736) (110,336) (90,852) (102,846) (164,178) (43,963) (144,301) (115,625) (209,388) 302,137 (75,785) (73,233) (70,419) (63,664) 5,246 (37,190) (44,622) (25,120)
Net income 1,202,849 1,088,416 824,527 945,851 836,446 601,541 582,534 741,375 684,654 697,837 978,795 1,026,065 805,398 730,660 717,517 1,068,485 633,058 567,170 456,983 420,142 410,315 78,009 380,305 346,396
Net (income) loss attributable to non-controlling interest (74) (24) (88) (73) (68) (80) 326 268 425 938 443 250 129
Net income attributable to KLA 1,202,849 1,088,416 824,527 945,851 836,446 601,541 582,534 741,375 684,654 697,837 978,795 1,025,991 805,374 730,572 717,444 1,068,417 632,978 567,496 457,251 420,567 411,253 78,452 380,555 346,525

Based on: 10-K (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-Q (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-K (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-Q (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-K (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-Q (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-K (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-Q (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-K (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-Q (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-K (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-Q (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30).


Revenue Trends
The company's product revenues exhibited growth from September 2019 to December 2022, reaching a peak of approximately $2.46 billion. Starting in March 2023, product revenues declined sharply before stabilizing and rising again toward the end of 2024 and early 2025. Service revenues showed a consistent upward trend over the entire period, increasing steadily from about $355 million in September 2019 to over $700 million by June 2025. Overall revenues reflected this combined pattern, with a general growth trajectory interrupted by a noticeable dip between late 2022 and early 2023, followed by recovery and further growth into 2025.
Cost of Revenues and Gross Margin
Costs of revenues increased over time, from approximately $604 million in September 2019 to a peak near $1.21 billion in December 2024, showing a rising cost structure. Gross margin figures paralleled the revenue trend, increasing substantially up to December 2022 (about $1.78 billion) before declining sharply in early 2023. They then gradually improved again into 2025, reaching nearly $2 billion. The gross margin fluctuations suggest that cost management faced challenges during periods of revenue decline but improved with the revenue recovery.
Operating Expenses
Research and development expenses steadily increased, beginning at roughly $211 million in September 2019 and rising to about $353 million by June 2025, indicating continuous investment in innovation and product development. Selling, general and administrative (SG&A) expenses followed a similar upward trend, increasing from approximately $188 million to $263 million over the same period. Both expense categories showed no significant reductions despite some revenue volatility, reflecting sustained investment in operations and corporate functions.
Impairment Charges
Impairment of goodwill and purchased intangible assets was recorded sporadically, with large charges noted in March 2020, September 2023, and March 2024. These impairments significantly impacted income from operations during these periods, indicating reassessments of asset values which negatively affected profitability.
Profitability and Income Analysis
Income from operations generally increased from $410 million in September 2019 to above $1.19 billion by December 2022, reflecting operational leverage from increasing revenues. However, the impairment charges and revenue dips in early 2023 caused a marked decline in operating income during that year. Interest expenses remained relatively stable with minor fluctuations. Other income (expense), net, showed considerable volatility, with both positive and negative values, indicating variable non-operating items influencing overall income.
Income Before Taxes and Net Income
Income before income taxes rose in line with operating income, showing a substantial increase through 2022 followed by volatility in 2023 and recovery in subsequent quarters. The tax provision exhibited significant variability, including some quarters with tax benefits and others with high tax expenses, impacting net income figures accordingly. Net income attributable to the company followed the general trend of income before taxes, with peaks in late 2021 and 2022 followed by dips in early 2023, then a sustained upward trajectory through mid-2025, ultimately surpassing earlier highs.
Key Observations
The financial data show that the company experienced strong growth in revenues and profitability up to late 2022, supported by steady increases in product and service revenues. Despite a pronounced period of impairment charges and revenue contraction in early 2023, operational resilience and cost control enabled a return to growth. Investment in R&D and SG&A remained elevated throughout, reflecting a commitment to innovation and market presence. The volatility in tax provisions and other income suggests fluctuating external factors affecting bottom-line results. Overall, the trends indicate a capacity for recovery and sustained growth following short-term disruptions.